Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04151381
Other study ID # Beni-Suef Hospital, operation
Secondary ID
Status Recruiting
Phase Phase 1
First received
Last updated
Start date November 2019
Est. completion date December 2019

Study information

Verified date September 2019
Source Beni-Suef University
Contact Samaa ak Rashwan, MD
Phone 020120159125
Email samakassemrashwan@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Several clinical studies and case reports suggested that aminophylline antagonizes the effects of diazepam , barbiturates , sevoflurane ,morphineand propofol.However, the available results from uncontrolled clinical settings make it difficult to quantify the specific effects of aminophylline on hypnotics and anesthetics


Description:

Aminophylline, a theophylline derivative, exerts multiple pharmacological effects, either through phosphodiesterase inhibition (i.e., a potent bronchodilating action, which is often used for the treatment of bronchial asthma) or via adenosine receptor blockade .It is generally considered that the majority of actions ascribed to therapeutic doses of xanthines (caffeine and theophylline) are due to their action as adenosine receptor antagonists.

To the best of the investigator's knowledge this hypothesis was not reported in patients scheduled for major pelvi-abdominal surgeries under general anesthesia , and aminophylline was not given as premedication to test this hypothesis as it was previously administrated after the end of surgery ,also it was recommended by previous clinical studies to evaluate the effective dose of aminophylline that affect the extubation and recovery time.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients age: 20-60 years

- Males and females patients

- American Society Of Anesthesiology (ASA) physical status I- II .

Exclusion Criteria:

- Patient refusal to participate in this study

- Patient with known sensitivity to aminophylline

- Patients with history of cardiac failure

- Patients with renal or hepatic dysfunction and in chronic alcoholism since clearance of aminophylline is decreased.

- Patients with peptic ulcer, hyperthyroidism, glaucoma,as these conditions may be exacerbated.

- Patients with opioid addiction

- Current treatment with B agonists, anticholinergic agents, tranquilizers, anticonvulsants ,or antidepressants.

- Pregnancy.

- Habitual coffee consumption exceeding 2 cups per day.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Aminophylline
the control group (n =15 ) the patients will receive 20 ml of normal saline IV ,20 minutes before induction of general anesthesia . Amiopphylline 2mg:(n = 15) the patients will receive 2 mg/kg intravenous (IV) aminophylline diluted in 20 ml normal saline 20 minutes before induction of general anesthesia . Aminophylline 4mg: (n = 15) the patients will receive 4 mg/kg intravenous (IV) aminophylline diluted in 20 ml normal saline 20 minutes before induction of general anesthesia .The study drugs will be given by an anesthetist unaware of the study protocol.

Locations

Country Name City State
Egypt Beni-Suef University Hospital Bani Suwayf
Egypt Faculty of Medicine, Beni-SuefUniversity Bani Suwayf

Sponsors (1)

Lead Sponsor Collaborator
Beni-Suef University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary times to lose consciousness( LOC) Times to lose of consciousness( LOC) which is defined as an OAA/S score 2 (loss of responsiveness to light tapping on shoulderor mild shaking with voice command to open eyes) from the first second after administration of the anesthetic drugs and for 1-5 minutes
See also
  Status Clinical Trial Phase
Completed NCT01851005 - Effect of Dexmedetomidine on Recovery Profiles of Elderly Patients N/A
Completed NCT01477398 - Improved Patient Recovery After Anesthesia Phase 0